Skip to content

Comparison of the effect of chamomile with danazol on women's mastalgia

A comparative study on the effect of Matricaria chamomilla and danazol on mastalgia in women of reproductive age

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171030037093N5
Enrollment
100
Registered
2019-03-29
Start date
2018-11-01
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastalgia. Mastodynia

Interventions

Intervention 1: Intervention group: patients use chamomile capsule made by barij essence company 250 mg 3 times a day. Also if there was more need to pain relief they use 100 mg danazole capsule up to

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 49 Years

Inclusion criteria

Inclusion criteria: Healthy women of Reproductive age Women with mastalgia score equal to or greater than four on the visual analog scale Women whose pain lasts more than 5 days each month. Clinical examination and mammography performed in the patient are normal. Patient does not have a known history of breast disease or malignancy. Patient does not have pulmonary, cardiovascular and costochondritis disease. Patient has no family history of breast cancer. Patient has no history of breast mass or secretion of the breast. Patient has satisfiction for participation in the study and has signed the consent form.

Exclusion criteria

Exclusion criteria: Women with physical and mental illness. Obese patients (Body mass index equal to or greater than 35) Women who are continuously taking medication. Women who have undergone hormone therapy in the last three months.

Design outcomes

Primary

MeasureTime frame
Mastalgia score. Timepoint: Before the intervention begins, 4 and 8 weeks after the intervention begins. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasool Rahimi

Shahre-kord University of Medical Sciences

rahimi.r@skums.ac.ir+98 38 3334 2414

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026